Healthcare regulatory body: potential risk assessment in mammography facilities.

This study presented the role of regulatory bodies in promoting patient safety and benefits within mammography facilities. The model of potential risk assessment method was applied over 4 yrs (2019-2023). An instrument based on national and state mammography normative objective inspection script was created to harmonize the regulatory actions. The study recorded average glandular dose (AGD) over 4 y, with data categorized by mammography unit manufacturer and model. According to the mammographic manufacturer and model, the AGD ranged from 1.03 to 5 mGy. The inspection results related to the risk potential assessment; the onsite inspection resulted in 29 mammography services as acceptable, 12 as unacceptable, and 14 as tolerable. The potential risk assessment strategy implemented provided a robust regulatory framework and reflected a positive impact on patient safety.